New study uses AI and genetics to unlock secrets of gut diseases

NCT ID NCT07556328

Recruiting now Knowledge-focused Sponsor: Tampere University Hospital Source: ClinicalTrials.gov ↗

First seen May 01, 2026 · Last updated May 12, 2026 · Updated 1 time

Summary

This study is collecting tissue samples from 300 people to improve how doctors diagnose small-bowel diseases like celiac disease. Researchers will use advanced tools like AI and genetic analysis to create more accurate reference values and diagnostic methods. The goal is to better understand these conditions and improve treatment monitoring.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hatanpää Specialist Medical Care
RECRUITING

Tampere, 33720, Finland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Tampere University Hospital (Tays)
RECRUITING

Tampere, 33720, Finland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Valkeakoski Regional Hospital
RECRUITING

Valkeakoski, 33720, Finland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CELIAC DISEASE REFRACTORY CELIAC DISEASE SMALL BOWEL DISEASE